OTLK logo

Outlook Therapeutics (OTLK) EBIT

Annual EBIT

-$72.21 M
-$15.76 M-27.92%

September 30, 2024


Summary


Performance

OTLK EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherOTLKprofitabilitymetrics:

Quarterly EBIT

$5.69 M
-$38.72 M-87.18%

September 1, 2024


Summary


Performance

OTLK Quarterly EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherOTLKprofitabilitymetrics:

TTM EBIT

$20.84 M
+$18.68 M+866.71%

September 1, 2024


Summary


Performance

OTLK TTM EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherOTLKprofitabilitymetrics:

EBIT Formula

EBIT = Revenue − COGS − Operating Expenses

OTLK EBIT Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-27.9%+155.1%+141.0%
3 y3 years-38.3%+143.3%+139.9%
5 y5 years-109.5%+213.7%+155.3%

OTLK EBIT Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-38.3%at low-87.2%+127.5%at high+131.1%
5 y5-year-109.5%at low-87.2%+127.5%at high+131.1%
alltimeall time-482.7%at low-87.2%+125.8%at high+131.1%

Outlook Therapeutics EBIT History

DateAnnualQuarterlyTTM
Sep 2024
-$72.21 M(+27.9%)
-
-
Sep 2024
-
$5.69 M(-87.2%)
$20.84 M(+866.7%)
Jun 2024
-
$44.41 M(-334.5%)
$2.16 M(-103.4%)
Mar 2024
-
-$18.94 M(+83.5%)
-$62.93 M(+23.8%)
Dec 2023
-
-$10.32 M(-20.5%)
-$50.83 M(-9.5%)
Sep 2023
-$56.45 M(-12.6%)
-$12.99 M(-37.2%)
-$56.19 M(-4.2%)
Jun 2023
-
-$20.67 M(+202.4%)
-$58.68 M(+6.6%)
Mar 2023
-
-$6.84 M(-56.4%)
-$55.03 M(-18.0%)
Dec 2022
-
-$15.69 M(+1.4%)
-$67.10 M(+2.4%)
Sep 2022
-$64.56 M(+23.6%)
-$15.48 M(-9.1%)
-$65.52 M(+3.7%)
Jun 2022
-
-$17.02 M(-10.0%)
-$63.18 M(+8.8%)
Mar 2022
-
-$18.91 M(+34.0%)
-$58.10 M(+11.6%)
Dec 2021
-
-$14.11 M(+7.4%)
-$52.04 M(-0.4%)
Sep 2021
-$52.23 M(+42.1%)
-$13.14 M(+10.0%)
-$52.23 M(+6.6%)
Jun 2021
-
-$11.94 M(-7.1%)
-$48.99 M(+14.2%)
Mar 2021
-
-$12.85 M(-10.1%)
-$42.90 M(+22.4%)
Dec 2020
-
-$14.30 M(+44.4%)
-$35.05 M(-4.6%)
Sep 2020
-$36.76 M(+6.6%)
-$9.90 M(+69.5%)
-$36.76 M(-6.6%)
Jun 2020
-
-$5.84 M(+16.8%)
-$39.37 M(+4.5%)
Mar 2020
-
-$5.00 M(-68.7%)
-$37.67 M(-10.0%)
Dec 2019
-
-$16.01 M(+27.8%)
-$41.85 M(+21.4%)
DateAnnualQuarterlyTTM
Sep 2019
-$34.47 M(+15.5%)
-$12.52 M(+202.7%)
-$34.47 M(+2.8%)
Jun 2019
-
-$4.14 M(-55.0%)
-$33.54 M(-8.6%)
Mar 2019
-
-$9.19 M(+6.6%)
-$36.69 M(+7.5%)
Dec 2018
-
-$8.62 M(-25.6%)
-$34.12 M(+14.3%)
Sep 2018
-$29.85 M(-8.8%)
-$11.59 M(+59.1%)
-$29.85 M(+35.8%)
Jun 2018
-
-$7.28 M(+10.1%)
-$21.99 M(+20.2%)
Mar 2018
-
-$6.62 M(+52.0%)
-$18.29 M(-1.0%)
Dec 2017
-
-$4.35 M(+16.8%)
-$18.47 M(-43.6%)
Sep 2017
-$32.72 M(-36.3%)
-$3.73 M(+4.0%)
-$32.72 M(-16.0%)
Jun 2017
-
-$3.59 M(-47.3%)
-$38.95 M(-32.1%)
Mar 2017
-
-$6.80 M(-63.4%)
-$57.39 M(+7.2%)
Dec 2016
-
-$18.61 M(+86.9%)
-$53.54 M(+4.3%)
Sep 2016
-$51.35 M(+10.3%)
-$9.95 M(-54.8%)
-$51.35 M(-12.6%)
Jun 2016
-
-$22.03 M(+645.7%)
-$58.77 M(+23.0%)
Mar 2016
-
-$2.95 M(-82.0%)
-$47.78 M(-18.8%)
Dec 2015
-
-$16.41 M(-5.5%)
-$58.83 M(+26.4%)
Sep 2015
-$46.56 M(+275.7%)
-$17.37 M(+57.3%)
-$46.56 M(+59.5%)
Jun 2015
-
-$11.05 M(-21.1%)
-$29.19 M(+60.9%)
Mar 2015
-
-$14.00 M(+237.9%)
-$18.14 M(+337.9%)
Dec 2014
-
-$4.14 M
-$4.14 M
Sep 2014
-$12.39 M
-
-

FAQ

  • What is Outlook Therapeutics annual earnings before interest & taxes?
  • What is the all time high annual EBIT for Outlook Therapeutics?
  • What is Outlook Therapeutics annual EBIT year-on-year change?
  • What is Outlook Therapeutics quarterly earnings before interest & taxes?
  • What is the all time high quarterly EBIT for Outlook Therapeutics?
  • What is Outlook Therapeutics quarterly EBIT year-on-year change?
  • What is Outlook Therapeutics TTM earnings before interest & taxes?
  • What is the all time high TTM EBIT for Outlook Therapeutics?
  • What is Outlook Therapeutics TTM EBIT year-on-year change?

What is Outlook Therapeutics annual earnings before interest & taxes?

The current annual EBIT of OTLK is -$72.21 M

What is the all time high annual EBIT for Outlook Therapeutics?

Outlook Therapeutics all-time high annual earnings before interest & taxes is -$12.39 M

What is Outlook Therapeutics annual EBIT year-on-year change?

Over the past year, OTLK annual earnings before interest & taxes has changed by -$15.76 M (-27.92%)

What is Outlook Therapeutics quarterly earnings before interest & taxes?

The current quarterly EBIT of OTLK is $5.69 M

What is the all time high quarterly EBIT for Outlook Therapeutics?

Outlook Therapeutics all-time high quarterly earnings before interest & taxes is $44.41 M

What is Outlook Therapeutics quarterly EBIT year-on-year change?

Over the past year, OTLK quarterly earnings before interest & taxes has changed by +$16.01 M (+155.13%)

What is Outlook Therapeutics TTM earnings before interest & taxes?

The current TTM EBIT of OTLK is $20.84 M

What is the all time high TTM EBIT for Outlook Therapeutics?

Outlook Therapeutics all-time high TTM earnings before interest & taxes is $20.84 M

What is Outlook Therapeutics TTM EBIT year-on-year change?

Over the past year, OTLK TTM earnings before interest & taxes has changed by +$71.66 M (+141.00%)